PARAGANGLION NEOPLASM MALIGNANT

This adverse event was reported 30 times

These drugs are most commonly taken by patients reporting PARAGANGLION NEOPLASM MALIGNANT:

# Drug Count
0 DACARBAZINE 8
1 CYCLOPHOSPHAMIDE 7
2 CYCLOPHOSPHAMIDE FOR INJECTION 7
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 7
4 EVEROLIMUS 5
5 TEMOZOLOMIDE 5
6 CARVEDILOL 4
7 EVEROLIMUS TABLETS 4
8 FENTANYL 4
9 ZOLEDRONIC ACID 4
See all common drugs associated with PARAGANGLION NEOPLASM MALIGNANT

PARAGANGLION NEOPLASM MALIGNANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METYROSINE 1 0.0123
1 DACARBAZINE 8 0.0011
2 EFGARTIGIMOD ALFA 1 0.0003
3 LANREOTIDE ACETATE 2 0.0003
4 TEMOZOLOMIDE 5 0.0002
5 EVEROLIMUS TABLETS 4 0.0002
6 LUTETIUM LU 177 DOTATATE 1 0.0002
7 INDAPAMIDE 2 0.0001
8 VINCRISTINE SULFATE 3 0.0001
9 EVEROLIMUS 5 0.0001
See all drugs enriched for association with PARAGANGLION NEOPLASM MALIGNANT

PARAGANGLION NEOPLASM MALIGNANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Catecholamine Synthesis Inhibitor [EPC] 1 0.0123
1 Neonatal Fc Receptor Blocker [EPC] 1 0.0002
2 Thiazide-like Diuretic [EPC] 2 0.0000
3 Alkylating Drug [EPC] 10 0.0000
4 alpha-Adrenergic Blocker [EPC] 4 0.0000
5 Opioid Agonist [EPC] 4 0.0000
6 beta-Adrenergic Blocker [EPC] 4 0.0000
7 Topoisomerase Inhibitor [EPC] 1 0.0000
8 Aminosalicylate [EPC] 1 0.0000
9 RANK Ligand Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with PARAGANGLION NEOPLASM MALIGNANT